Structure and Expression of Calponin in Arterial Smooth Muscle Cells

  • Hisako Yamamura
  • Wataru Ikeda
  • Nobuhiko Shibata
  • Nobuhisa Awata
  • Katsuhito Takahashi
Part of the Progress in Experimental Cardiology book series (PREC, volume 1)


The gene and cDNA clones encoding smooth muscle calponin (also called basic calponin or calponin h1) have been isolated and characterized. The NH2-terminal region of calponin shares homology with a putative negative regulatory domain of the GDP-GTP exchanger for Rho-like GTP-binding proteins. Expression of the basic isoform of calponin is downmodulated in proliferating smooth muscle cells of atherosclerotic neointima and injured arterial media. Transfer of the recombinant human calponin gene into rabbit balloon-injured arteries or rat transgenic arteries in vivo increased calponin expression by smooth muscle cells and suppressed arterial myointimal hyperplasia. The cellular distribution of calponin has been shown to be dramatically changed upon stimulation. with an agonist known to activate protein kinase C in vascular smooth muscle cells. In addition to regulation of the contraction-relaxation cycle of smooth muscle, the findings reviewed here suggest that calponin might also be involved in the control of adhesion, migration, and proliferation of smooth muscle cells.


Balloon Injury Myosin Binding Site Medial SMCs Senescent Human Fibroblast Carotid Artery Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Takahashi K, Hiwada K, Kokubu T. 1986. Isolation and characterization of a 34,000-dalton calmodulin-and F-actin-binding protein from chicken gizzard smooth muscle. Biochem Biophys Res Commun 141:20–26.PubMedCrossRefGoogle Scholar
  2. 2.
    Takahashi K, Hiwada K, Kokubu T. 1987. Occurrence of antigizzard p34K antibody cross-reactive components in bovine smooth muscles and non-smooth muscle tissues. Life Sci 41:291–296.PubMedCrossRefGoogle Scholar
  3. 3.
    Takahashi K, Hiwada K, Kokubu T. 1988. Vascular smooth muscle calponin: a novel troponin T-like protein. Hypertension 11:620–626.PubMedGoogle Scholar
  4. 4.
    Takahashi K, Abe M, Hiwada K, Kokubu T. 1988. A novel troponin T-like protein (calponin) in vascular smooth muscle: interaction with tropomyosin paracrystals. J Hypertens 6:S40–S43.Google Scholar
  5. 5.
    Takahashi K, Nadal-Ginard B. 1991. Molecular cloning and sequence analysis of smooth muscle calponin. J Biol Chem 266: 13284–13288.PubMedGoogle Scholar
  6. 6.
    Nishida W, Abe M, Takahashi K, Hiwada K. 1990. Do thin filaments of smooth muscle contain calponin? A new method for the preparation. FEBS Lett 268:165–168.PubMedCrossRefGoogle Scholar
  7. 7.
    Gimona M, Herzog M, Vandekerckhove J, Small JV. 1990. Smooth muscle specific expression of calponin. FEBS Lett 274:159–162.PubMedCrossRefGoogle Scholar
  8. 8.
    Takeuchi K, Takahashi K, Abe M, Nishida W, Hiwada K, Nabeya T, Maruyama K. 1991. Co-localization of immunoreactive forms of calponin with actin cytoskeleton in platelets, fibroblasts, and vascular smooth muscle. J Biochem (Tokyo) 109:311–316.Google Scholar
  9. 9.
    Lehman W. 1991. Calponin and the composition of smooth muscle thin filaments. J Muscl Res Cell Motil 12:221–224.CrossRefGoogle Scholar
  10. 10.
    Marston SB. 1991. Properties of calponin isolated from sheep aorta thin filaments. FEBS Len 292:179–182.CrossRefGoogle Scholar
  11. 11.
    Birukov KG, Stepanova OV, Nanaev AK, Shrinsky VP. 1991. Expression of calponin in rabbit and human aortic smooth muscle cells. Cell Tissue Res 31:16–21.Google Scholar
  12. 12.
    Walsh MP, Camichael JD, Kargacin GJ. 1993. Characterization and confocal imaging of calponin in gastrointestinal smooth muscle. Am J Physiol 265:C1371–C1378.PubMedGoogle Scholar
  13. 13.
    North AJ, Gimona M, Cross RA, Small JV. 1994. Calponin is localized in both the contractile apparatus and the cytoskeleton of smooth muscle cells. J Cell Sci 107:437–444.PubMedGoogle Scholar
  14. 14.
    Parker CA, Takahashi K, Tao T, Morgan KG. 1994. Agonist-induced redistribution of calponin in contractile vascular smooth muscle cells. Am J Physiol 267:C1262–C1270.PubMedGoogle Scholar
  15. 15.
    Itoh T, Suzuki S, Suzuki A, Nakamura F, Naka M, Tanaka T. 1994. Effects of exogenously applied calponin on Ca2+-regulated force in skinned smooth muscle of the rabbit mesenteric artery. Pflugers Arch 427:301–308.PubMedCrossRefGoogle Scholar
  16. 16.
    Jaworowski A, Anderson KI, Arner A, Engstrom M, Gimona M, Strasser P, Small JV. 1995. Calponin reduces shortening velocity in skinned taenia coli smooth muscle fibers. FEBS Lett 365:167–171.PubMedCrossRefGoogle Scholar
  17. 17.
    Obara K, Szymanski PT, Tao T, Paul R. 1996. Effects of calponin on isometric force and shortening velocity in permeabilized taenia coli smooth muscle. Am J Physiol 270:C481–C487.PubMedGoogle Scholar
  18. 18.
    Horowitz A, Clement-chomienne O, Walsh MP, Tao T, Katsuyama H, Morgan KG. 1996. Effects of calponin on force generation by single smooth muscle cells. Am J Physiol 270:H1858–H1863.PubMedGoogle Scholar
  19. 19.
    Winder SJ, Walsh MP. 1990. Smooth muscle calponin: inhibition of actomyosin Mg-ATPase and regulation by phosphorylation. J Biol Chem 265:10148–10155.PubMedGoogle Scholar
  20. 20.
    Abe M, Takahashi K, Hiwada K, 1990. Effect of calponin on actin-activated myosin ATPase activity. J Biochem (Tokyo) 108:835–838.Google Scholar
  21. 21.
    Horiuchi KY, Chacko S. 1991. The mechanism for the inhibition of actin-activated ATPase of smooth muscle heavy meromyosin by calponin. Biochem Biophys Res Commun 176:1487–1493.PubMedCrossRefGoogle Scholar
  22. 22.
    Makuch R, Birukov K, Shrinsky V, Dabrowska R. 1991. Functional interrelationship between calponin and caldesmon. Biochem J 280:33–38.PubMedGoogle Scholar
  23. 23.
    Miki M, Walsh MP, Hartshorne DJ. 1992. The mechanism of inhibition of the actin-activated myosin MgATPase by calponin. Biochem Biophys Res Commun 187:867–871.PubMedCrossRefGoogle Scholar
  24. 24.
    Winder SJ, Sutherland C, Walsh MP. 1992. A comparison of the effects of calponin on smooth and skeletal muscle actomyosin systems in the presence and absence of caldesmon. Biochem J 288:733–739.PubMedGoogle Scholar
  25. 25.
    Shrinsky V, Birukov KG, Hettasch JM, Sellers JR. 1992. Inhibition of the relative movement of actin and myosin by caldesmon and calponin. J Biol Chem 267:15886–15892.Google Scholar
  26. 26.
    Gong B-J, Mabuchi K, Takahashi K, Nadal-Ginard B, Tao T. 1993. Characterization of wild type and mutant chicken gizzard alpha calponin expressed in E. Coli. J Biochem 114:453–456.PubMedGoogle Scholar
  27. 27.
    Haeberle JR. 1994. Calponin decreases the rate of cross-bridge cycling and increases miximum force production by smooth muscle myosin in an in vitro motility assay. J Biol Chem 269:12424–12431.PubMedGoogle Scholar
  28. 28.
    EL-Mezgueldi M, Marston SV. 1996. The effects of smooth muscle calponin on the strong and weak myosin binding sites of F-actin. J Biol Chem 271:28161–28167.PubMedCrossRefGoogle Scholar
  29. 29.
    Strasser P, Gimona M, Moessler H, Herzog M, Small JV. 1993. Mammalian calponin: identification and expression of genetic variants. FEBS Lett 330:13–18.PubMedCrossRefGoogle Scholar
  30. 30.
    Applegate D, Feng W, Green RS, Taubman MB. 1994. Cloning and expression of a novel acidic calponin isoform from rat aortic vascular smooth muscle. J Biol Chem 269:10683–10690.PubMedGoogle Scholar
  31. 31.
    Masuda H, Tanaka K, Takagi M, Ohgami K, Sakamaki T, Shibata N, Takahashi K. 1996. Molecular cloning and characterization of human non-smooth muscle calponin. J Biochem 120:415–424.PubMedGoogle Scholar
  32. 32.
    Samaha FF, Ip HS, Morrisey EE, Seltzer J, Tang Z, Solway J, Parmacek MS. 1996. Developmental pattern of expression and genomic organization of the calponin-h1 gene. A contractile smooth, muscle cell marker. J Biol Chem 271:395–403.PubMedCrossRefGoogle Scholar
  33. 33.
    Gao J, Hwang JM, Jin J-P. 1996. Complete nucleotide sequence, structural organization, and an alternatively spliced exon of mouse h1-calponin gene. Biochem Biophys Res Commun 218:292–297.PubMedCrossRefGoogle Scholar
  34. 34.
    Miano JM, Olson EN. 1996. Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem 271:7095–7103.PubMedCrossRefGoogle Scholar
  35. 35.
    Trabelsi-Terzidis H, Fattoum A, Represa A, Dessi F, Ben-Ari Y. 1995. Expression of an acidic isoform of calponin in rat brain: Western blots on one-or two-dimensional gels and immuno-localization in cultured cells. Biochem J 306:211–215.PubMedGoogle Scholar
  36. 36.
    Lees-Miller JP, Heeley DH, Smillie LB, Kay CM. 1987. Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle. J Biol Chem 262:2988–2993.PubMedGoogle Scholar
  37. 37.
    Thweatt R, Lumpkin CK Jr, Goldstein S. 1992. A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts. Biochem Biophys Res Commun 187:1–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Vancompernolle K, Gimona M, Herzog M, Van Damme J, Vandekerckhove J, Small V. 1990. Isolation and sequence of a tropomyosin-binding fragment of turkey gizzard calponin. FEBS Lett 274:146–150.PubMedCrossRefGoogle Scholar
  39. 39.
    Goetink S, Waterston RH. 1994. The Caenorhabditis elegans UNC-87 protein is essential for maintenarce, but not assembly, of bodywall muscle. J Cell Biol 127:71–78.CrossRefGoogle Scholar
  40. 40.
    Goetink S, Waterston RH. 1994. The Caenorhabditis elegans muscle-affecting gene unc-87 encodes a novel thin filament associated protein. J Cell Biol 127:79–93.CrossRefGoogle Scholar
  41. 41.
    Katzav S, Cleveland JL, Heslop HE, Pulido D. 1991. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol 11:1912–1920.PubMedGoogle Scholar
  42. 42.
    Coppola J, Bryant S, Koda T, Conway D, Barbacid M. 1991. Mechanism of activation of the vav protooncogene. Cell Growth Differ 2:95–105.PubMedGoogle Scholar
  43. 43.
    Adams JM, Houston H, Allen J, Lints T, Harvey R. 1992. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7:611–618.PubMedGoogle Scholar
  44. 44.
    Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B, Griffin JD. ••. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, TL-3 and Steel factor and is constitutively increased by p210BCR/ABL. EMBO J 14:257–265.Google Scholar
  45. 45.
    Sloat BF, Adams A, Pringle JR. 1981. Roles of the CDC24 gene product in cellular morphogenesis during the Saccharomyces cervisiae cell cycle. J Cell Biol 89:395–405.PubMedCrossRefGoogle Scholar
  46. 46.
    Hirata K, Gkuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K, Takai Y. 1992. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 267:8719–8722.PubMedGoogle Scholar
  47. 47.
    Habets GGM, Scholtes EHM, Zuydgeest D, van der Kammen RA, Stam JC, Berns A, Collard JG. 1994. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchange for rho-like proteins. Cell 77:537–549.PubMedCrossRefGoogle Scholar
  48. 48.
    Gimona M, Sparrow MP, Strasser P, Herzog M, Small JV. 1992. Calponin and SM22 isoforms in avian and mammalian smooth muscle: absence of phosphorylation in vivo. Eur J Biochem 205:1067–1075.PubMedCrossRefGoogle Scholar
  49. 49.
    Duband J-L, Gimona M, Scatena M, Sartore S, Small JV. 1993. Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation 55:1–11.PubMedCrossRefGoogle Scholar
  50. 50.
    Shanahan CM, Weissberg PL, Metcalfe JC. 1993. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73:193–204.PubMedGoogle Scholar
  51. 51.
    Shanahan C, Cary NRB, Metcalf JC, Weissberg PL. 1994. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393–2402.PubMedCrossRefGoogle Scholar
  52. 52.
    Negoro N, Fukui R, Tsuchikane E, Otsuji S, Kato O, Kobayashi T, Takagi M, Eshita Y, Nishida M, Kojima A, Takahashi K, Shibata N. 1994. Down expression of calponin in smooth muscle of coronary artery lesions identifies a group of lesions at high risk for restenosis after atherectomy: implications for human gene therapy by direct calponin gene transfer. Circulation 90:I–142.Google Scholar
  53. 53.
    Takahashi K, Fukui R, Kato O, Nakazawa S, Takagi M, Kinoshita I, Hiraishi T, Kojima A, Sato S, Eshita Y, Fujio Y, Kobayashi T, Shibata N. 1993. Percutaneous transluminal transfer of the human calponin gene for suppression of intimal hyperplasia following arterial balloon injury: a model for successful gene therapy for restenosis. Circulation 88: I–657.Google Scholar
  54. 54.
    Takahashi K, Miwa A, Takagi M, Kojima A, Eshita Y, Nara Y, Yamori Y, Hirabayashi M, Kato O, Awata N, Kobayashi T, Shibata N. 1995. Overexpression of calponin in transgenic rats inhibits intimal arterial smooth muscle cell hyperplasia in the carotid artery model of restenosis. Circulation 92:I–295.Google Scholar
  55. 55.
    Takahashi K, Takagi M, Ohgami K, Nakai M, Kojima A, Nadal-Ginard B, Shibata N. 1993. Inhibition of smooth muscle cell migration and proliferation caused by transfection of the human calponin gene is associated with enhanced cell matrix adhesion and reduced PDGF responsiveness. Circulation 88:I–174.Google Scholar
  56. 56.
    EL-Mezgueldi M, Strasser P, Fattoum A, Gimona M. 1996. Expressing functional domains of mouse calponin: involvement of the region around alanine 145 in the actomyosin ATPase inhibitory activity of calponin. Biochemistry 35:3654–3661.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Hisako Yamamura
    • 1
  • Wataru Ikeda
    • 1
  • Nobuhiko Shibata
    • 1
  • Nobuhisa Awata
    • 1
  • Katsuhito Takahashi
    • 1
  1. 1.Osaka Medical Center for Cancer and Cardiovascular DiseasesJapan

Personalised recommendations